Pu Jia

Pu Jia is a notable inventor based in Shaanxi, China. He has made significant contributions to the field of cardiovascular health through his innovative research and patents. His work focuses on the prevention and treatment of coronary atherosclerosis disease, which is a critical health issue affecting many individuals worldwide.

Latest Patents

Pu Jia holds a patent for the use of isopropyl β-(3,4-dihydroxyphenyl)-α-hydroxypropionate (IDHP) in the preparation of a drug or health product aimed at preventing and treating coronary atherosclerosis diseases. This patent highlights the potential of IDHP not only in addressing coronary issues but also in inhibiting platelet aggregation and promoting angiogenesis. Furthermore, it can be utilized in developing treatments for senile vascular dementia, showcasing its versatility in addressing various health concerns. He has 1 patent to his name.

Career Highlights

Pu Jia is affiliated with Northwest University, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential impact on public health, particularly in the realm of cardiovascular diseases. His dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

Pu Jia collaborates with esteemed colleagues, including Xiaohui Zheng and Yajun Bai. Their combined expertise enhances the research efforts and contributes to the advancement of knowledge in cardiovascular health.

Conclusion

Pu Jia's contributions to the field of cardiovascular health through his innovative patent demonstrate his commitment to improving health outcomes. His work not only addresses critical health issues but also paves the way for future research and development in this vital area.

Profile summary based on public USPTO records.